Search stocks

Find any stock by ticker or company name

Get all premium features to the best stock analysis tool

Finranks

Company

About us

Contact us

[email protected]

Follow us

Instagram
Telegram
LinkedIn

All rights reserved.

Privacy Policy Terms of Conditions

Home
Watchlist
Markets
Calendar
Screener
News
About

ELV - Elevance Health, Inc. Financial Statements | Finranks

Home

/

ELV

E

Elevance Health, Inc. (ELV)

NYQ – Real Time Price. Currency in USD

398.21

+7.84 (2.01%)

Market open: Aug 12, 2026, 3:47 PM EDT

387.62

-2.75 (-0.70%)

Previous after-hours: Aug 11, 2026, 7:34 PM EDT

Summary
News
Chart
Financial
Dividends
Forecast
Ownership
Profile

Revenue

Gross Profit

Operating Income

Net Income

Total Assets

Total Liabilities

Stockholders Equity

Total Debt

Operating Cash Flow

Investing Cash Flow

Financing Cash Flow

Free Cash Flow

Income Statement
Balance Sheet
Cash Flow

Income Statement (Annual)

Financials in millions USD. Fiscal year is January – December.

Name

2025

2024

2023

2022

Total Revenue

199.13B

176.81B

171.34B

156.59B

Cost of goods sold

-

-

-

-

Gross Profit

-

-

-

-

Operating expenses (excl. COGS)

-

-

-

-

Operating Income

8.11B

8.89B

8.74B

8.45B

Non-operating income, total

-1.40B

-984M

-1.03B

-851M

Pretax income

6.71B

7.90B

7.71B

7.60B

Equity in earnings

0

0

0

0

Taxes

-1.05B

-1.93B

-1.72B

-1.71B

Non-controlling/minority interest

1M

9M

-4M

6M

After tax other income/expense

0

0

0

0

Net income before discontinued operations

5.66B

5.98B

5.99B

5.89B

Discontinued operations

0

0

0

0

Net income

5.66B

5.98B

5.99B

5.89B

Dilution adjustment

0

0

0

0

Preferred dividends

0

0

0

0

Name

2025

2024

2023

2022

Total assets

121.49B+3.9%

116.89B+7.3%

108.93B+6.0%

102.75B

Total current assets

63B

58.94B

60.03B

55.62B

Total non-current assets

-

-

-

-

Total liabilities

77.47B+2.7%

75.46B+8.5%

69.52B+4.7%

66.42B

Total current liabilities

41.03B

40.58B

41.79B

39.70B

Total non-current liabilities

-

-

-

-

Total equity

44.03B

41.43B

39.41B

36.33B

Total liabilities & shareholders' equities

121.49B

116.89B

108.93B

102.75B

Total debt

32.71B+2.1%

32.04B+23.4%

25.97B+3.7%

25.05B

Name

2025

2024

2023

2022

Cash from operating activities

4.29B

5.81B

8.06B

8.40B

Cash from investing activities

-1.34B

-5.17B

-5.57B

-4.56B

Cash from financing activities

-1.74B

1.19B

-3.35B

-1.32B

Free cash flow

3.17B-30.3%

4.55B-32.7%

6.76B-6.7%

7.25B